Skip to content

A single center, randomized, self-controlled study of picosecond laser in the treatment of chloasma and facial rejuvenation

A single center, randomized, self-controlled study of picosecond laser in the treatment of chloasma and facial rejuvenation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065607
Enrollment
Unknown
Registered
2022-11-09
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma

Interventions

dot picosecond laser group:dot picosecond laser
focus fractional picosecond laser group:focus fractional picosecond laser

Sponsors

Department of Laser and Aesthetic Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. 18-60 years old, female; 2. Clinically diagnosed as chloasma patients, accompanied by thick pores or wrinkles; 3. Melasma lesions are bilateral and symmetrical; 4. Signed informed consent;

Exclusion criteria

Exclusion criteria: 1. There are other severe facial spots or pigmentation, which may affect the efficacy evaluation; 2. Similar treatment or clinical trial within the last 3 months; 3. Recent exposure history; 4. Photosensitive or used photosensitive drugs within 2 weeks; 5. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Grade of melasma improvement;Melasma area severity index,MASI;

Secondary

MeasureTime frame
VISIA score;

Countries

China

Contacts

Public ContactGang Ma

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine

docmagang@126.com+86 13761130439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026